The Claim

In cognitively unimpaired older adults aged 65–85 with elevated amyloid pathology, higher baseline plasma phosphorylated tau-217 levels are associated with a faster rate of cognitive decline over 4.5 years as measured by the Primary Alzheimer Cognitive Composite, with the highest tertile showing the steepest decline, and this association is stronger than that with amyloid PET.

Source: Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
65score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

In older adults with early signs of Alzheimer’s brain changes but no cognitive symptoms, higher levels of a specific protein in the blood called phosphorylated tau-217 are linked to a faster loss of memory and thinking skills over 4.5 years, and this protein predicts decline better than brain scans of amyloid.

See the scientific wording

In cognitively unimpaired older adults aged 65–85 with elevated amyloid pathology, higher baseline levels of plasma phosphorylated tau-217 are associated with a faster rate of cognitive decline over 4.5 years, as measured by the Primary Alzheimer Cognitive Composite, with individuals in the highest tertile showing the steepest decline; this association is stronger than that observed with amyloid PET, suggesting plasma P-tau217 may be a more sensitive biomarker for tracking early neurodegenerative progression.

Why this might work

Excess amyloid in the brain activates enzymes that add phosphate groups to tau protein at a specific spot called 217. This modified tau misfolds and clumps into tangled fibers inside nerve cells, which breaks down the internal transport system, damages connections between neurons, and kills brain cells over time. As more neurons fail, thinking and memory skills decline rapidly.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies

    In older adults with no memory problems but early Alzheimer’s brain changes, a simple blood test for P-tau217 predicts who will lose thinking skills faster over four and a half years — better than brain scans of amyloid plaques.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.